Research Summaries

bacterial infections
bacterial infections
09/09/2020
The goal of the writing panel was to assist clinicians in all areas of medicine in selecting appropriate antibiotic therapies for common pathogens in an effort to combat antimicrobial resistance.
09/09/2020
Treatment
Treatment
03/05/2020
The IDSA published guidelines for the treatment of patients with Clostridioides difficile infection in 2018. But which of the recommended treatment regimens is most cost-effective? Researchers have the...
03/05/2020
Urology
Urology
11/15/2019
The new antibacterial drug was approved after it was proven safe and effective in a study of 448 patients with complicated UTIs.
11/15/2019
bacterial infections
bacterial infections
11/14/2019
In 2013, antibiotic-resistant organisms were responsible for nearly twice as many fatalities in the United States as previously reported, according to a new report from the US Centers for Disease Control...
11/14/2019
salmonella
salmonella
10/05/2019
The Centers for Disease Control and Prevention are currently investigating a multi-state outbreak of Salmonella Dublin infection that has been linked to ground beef.
10/05/2019
Gastrointestinal Disorders
Gastrointestinal Disorders
09/21/2019
Clostridium difficile is an anaerobic spore-forming bacterium. C difficile infection (CDI) is recognized as the leading cause of nosocomial diarrhea and is associated with substantial morbidity and...
09/21/2019
community-acquired pneumonia
community-acquired pneumonia
09/11/2019
The authors of a new study sought to identify a single panel of biomarkers and designate a point score that could predict treatment failure early in patients hospitalized with severe community-acquired...
09/11/2019
sepsis
sepsis
09/05/2019
Authors of a new analysis evaluated data on more than 2 million patients from the United States to determine the association of hospital-onset and community-onset sepsis with mortality risk.
09/05/2019
Lung Infections
Lung Infections
08/15/2019
After a clinical trial showed positive results in 89% of participants, a new drug regimen was approved by the FDA for highly drug-resistant forms of pulmonary tuberculosis.
08/15/2019
FDA
FDA
07/17/2019
A new 3-drug antibacterial drug injection containing an FDA-approved antibiotic and a new β-lactamase inhibitor has been approved.
07/17/2019